← Back to Search

Stent

Wingspan Stent System for Intracranial Artery Stenosis (WEAVE Trial)

N/A
Waitlist Available
Led By Michael J Alexander, M.D.
Research Sponsored by Stryker Neurovascular
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients for whom treatment with the Wingspan Stent System is considered
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 90 days post procedure
Awards & highlights

Summary

The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.

Eligible Conditions
  • Intracranial Artery Stenosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 90 days post procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 90 days post procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Stroke or Death Among Participants
Secondary outcome measures
Rate of Ischemic Stroke Among Participants
Rate of Neurological Death Among Participants
Rate of Stroke Recovery Among Participants
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Wingspan Stent SystemExperimental Treatment1 Intervention
Placement of the Wingspan Stent
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Wingspan Stent System
2013
N/A
~160

Find a Location

Who is running the clinical trial?

Stryker NeurovascularLead Sponsor
35 Previous Clinical Trials
12,587 Total Patients Enrolled
Michael J Alexander, M.D.Principal InvestigatorCedars-Sinai Medical Center
Wengui Yu, M.D.Principal InvestigatorUniversity of California, Irvine
~13 spots leftby Sep 2025